Placeholder Banner

Media Advisory: NexSteppe CEO Anna Rath to Receive BIO Award Honoring an Outstanding Woman in Industrial Biotechnology

April 14, 2016

What:  President and CEO of NexSteppe Anna Rath will deliver remarks and will be presented the Rosalind Franklin Award by the Biotechnology Innovation Organization (BIO) at the 2016 World Congress on Industrial Biotechnology in San Diego on Tuesday April 19. The Rosalind Franklin Award is presented annually to honor an outstanding woman in the field of industrial biotechnology and bioprocessing.

Date:           Tuesday, April 19, 2016
Time:          12:00pm PST - 2:15pm PST
Who:           Anna Rath, President & CEO, NexSteppe
Location:    Ballroom 6AB
                    San Diego Convention Center
                    111 W Harbor Dr, San Diego, CA 92101

 

Background: A special selection committee of scientists and leaders in the field chose Rath for her commitment to the advancement of the field of industrial biotechnology.  In 2010, Anna Rath founded NexSteppe to develop and commercialize optimized crops for renewable energy and fuel. In fewer than five years, Anna built NexSteppe to a global team of over 40 people. NextSteppe’s unique technology platform has allowed it to become the leader in bioenergy sorghums, first in Brazil and now globally. Under Rath’s leadership, NexSteppe is laying a foundation for a sustainable and secure future for our economy, our environment, and our energy supply.

The Rosalind Franklin Society is the sponsor of the 2016 BIO Rosalind Franklin Award.

All programs at the World Congress on Industrial Biotechnology are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.

For more information on the conference, please visit http://go.bio.org/WorldCongress2016.html. For assistance, please contact worldcongress@bio.org.

About BIO
BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org.


 

Discover More
Action plan outlines the policies needed to ensure that the biotechnology sector remains a driving force for America’s health, prosperity, national security, and geopolitical strengthWASHINGTON (November 10, 2026) - The Biotechnology Innovation…
Complaint argues HHS and CMS exceeded statutory authority; rule puts patient access, investment in future innovation, and America’s long-term biotechnology leadership at risk.WASHINGTON, DC & SAN DIEGO, CA & SAN FRANCISCO, CA - The…
WASHINGTON, DC (October 28, 2026) – Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact…